All Articles

Editorial Commentary 
Bexmarilimab and azacitidine: promise for immunotherapy in myelodysplastic syndrome?
Gina Keiffer, Margaret Kasner
Annals of Blood  
2026;
11:
20
.
Editorial Commentary 
Venetoclax and azacitidine in high-risk myelodysplastic syndromes: expectations vs. evidence
Angelo Rizzolo, Andrea Palasciano, Sarit Assouline
Annals of Blood  
2026;
11:
19
.
Editorial Commentary 
Chronic graft-versus-host disease: toward mechanism-based prevention and treatment
Angélica Villanueva Freije, Antonio Pérez-Martínez
Annals of Blood  
2026;
11:
18
.
Case Report 
APTT dynamics after susoctocog alfa for early diagnostic support in suspected acquired hemophilia A: a case report
Eiichiro Nagatani, Takeshi Hagino, Tomohiko Sato, Manabu Kamio
Annals of Blood  
2026;
11:
17
.
Case Report 
Transfusion-acquired transient hemoglobinopathies: a case report and review of the literature
Katherine Drews-Elger, Thomas J. Harrington, Afshan Idrees, Yanyun Wu, Derek C. Waggoner
Annals of Blood  
2026;
11:
16
.
Review Article 
Blood transfusion thresholds: a narrative review of the literature and recent guidelines
Opal Reddy, Gaurav K. Gupta, Sushant Kumar Meinia, Zaher K. Otrock, J. Peter R. Pelletier, Maria Roussakis, Janine Shepherd, Richard R. Gammon
Annals of Blood  
2026;
11:
14
.
Review Article 
Monoclonal B-cell lymphocytosis: what hematologists should know—a narrative review
Gabriel de Sousa Nobre, Lucas Cartaxo Tavares, Laura Azevedo de Moraes, Marina Almeida Simões, Daniel Mazza Matos
Annals of Blood  
2026;
11:
13
.
Review Article 
The history of hemoglobin-based oxygen carriers: a narrative review
Erica A. Swenson, Maryam Asif, Deborah Tolich, Gaurav K. Gupta, Joyisa Deb, Sarah Walbolt, Bruce Spiess
Annals of Blood  
2026;
11:
11
.
Editorial Commentary 
Low dose radiation in indolent lymphoma: from dose optimization to biological insight
Neil Ari Wijetunga
Annals of Blood  
2026;
11:
9
.
Editorial Commentary 
Improved therapy for paroxysmal nocturnal hemoglobinuria
David Dingli
Annals of Blood  
2026;
11:
8
.
Editorial Commentary 
Driving CAR-T therapy down the GPRC5D fast lane
Stanzin Idga, Justin Taylor
Annals of Blood  
2026;
11:
7
.
Review Article 
Demand forecast for plasma collections
Maik Klasen, Jason Brunton
Annals of Blood  
2026;
11:
3
.
Review Article 
New developments and future trends of artificial blood
Gopal Patidar, Arun Vazhappilly Jose, Rounak Dubey, Monique Huggins, Behnam Rafiee, Mordechai Hershkop, Jules Zinni, Bruce Spiess, Mark T. Friedman
Annals of Blood  
2026;
11:
1
.
Review Article 
The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura
Konstantine Halkidis
Annals of Blood  
2025;
10:
26
.
Review Article 
A holistic view of international regulations and industry standards governing collection of plasma and manufacture of plasma-derived medicinal products
James R. Knowles, Crystal Phillips, Evelina Kozubovska, Joshua Penrod, Julia Fabens
Annals of Blood  
2025;
10:
25
.
Review Article 
The blood feud: compensated versus non-compensated source plasma donations
Peter M. Jaworski
Annals of Blood  
2025;
10:
24
.
Review Article 
Source plasma apheresis and plasma-derived medicinal products: a historical review
Michelle Fransen, Toby Simon
Annals of Blood  
2025;
10:
22
.